Literature DB >> 19219741

Reactions of peroxynitrite with uric acid: formation of reactive intermediates, alkylated products and triuret, and in vivo production of triuret under conditions of oxidative stress.

Christine Gersch1, Sergiu P Palii, Witcha Imaram, Kyung Mee Kim, S Ananth Karumanchi, Alexander Angerhofer, Richard J Johnson, George N Henderson.   

Abstract

Hyperuricemia is associated with hypertension, metabolic syndrome, preeclampsia, cardio-vascular disease and renal disease, all conditions associated with oxidative stress. We hypothesized that uric acid, a known antioxidant, might become prooxidative following its reaction with oxidants; and, thereby contribute to the pathogenesis of these diseases. Uric acid and 1,3-(15)N(2)-uric acid were reacted with peroxynitrite in different buffers and in the presence of alcohols, antioxidants and in human plasma. The reaction products were identified using liquid chromatography-mass spectrometry (LC-MS) analyses. The reactions generate reactive intermediates that yielded triuret as their final product. We also found that the antioxidant, ascorbate, could partially prevent this reaction. Whereas triuret was preferentially generated by the reactions in aqueous buffers, when uric acid or 1,3-(15)N(2)-uric acid was reacted with peroxynitrite in the presence of alcohols, it yielded alkylated alcohols as the final product. By extension, this reaction can alkylate other biomolecules containing OH groups and others containing labile hydrogens. Triuret was also found to be elevated in the urine of subjects with preeclampsia, a pregnancy-specific hypertensive syndrome that is associated with oxidative stress, whereas very little triuret is produced in normal healthy volunteers. We conclude that under conditions of oxidative stress, uric acid can form reactive intermediates, including potential alkylating species, by reacting with peroxynitrite. These reactive intermediates could possibly explain how uric acid contributes to the pathogenesis of diseases such as the metabolic syndrome and hypertension.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19219741      PMCID: PMC2742358          DOI: 10.1080/15257770902736400

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  50 in total

1.  Risk factors for cardiovascular disease: one down, many more to evaluate.

Authors:  V Vaccarino; H M Krumholz
Journal:  Ann Intern Med       Date:  1999-07-06       Impact factor: 25.391

2.  Free radical metabolite of uric acid.

Authors:  K R Maples; R P Mason
Journal:  J Biol Chem       Date:  1988-02-05       Impact factor: 5.157

3.  Mechanism of nitrite formation by nitrate photolysis in aqueous solutions: the role of peroxynitrite, nitrogen dioxide, and hydroxyl radical.

Authors:  Sara Goldstein; Joseph Rabani
Journal:  J Am Chem Soc       Date:  2007-08-04       Impact factor: 15.419

4.  Metabolic fate of peroxynitrite in aqueous solution. Reaction with nitric oxide and pH-dependent decomposition to nitrite and oxygen in a 2:1 stoichiometry.

Authors:  S Pfeiffer; A C Gorren; K Schmidt; E R Werner; B Hansert; D S Bohle; B Mayer
Journal:  J Biol Chem       Date:  1997-02-07       Impact factor: 5.157

5.  Gibbs energy of formation of peroxynitrite--order restored.

Authors:  S Goldstein; G Czapski; J Lind; G Merényi
Journal:  Chem Res Toxicol       Date:  2001-06       Impact factor: 3.739

6.  Hyperuricemia and incidence of hypertension among men without metabolic syndrome.

Authors:  Eswar Krishnan; C Kent Kwoh; H Ralph Schumacher; Lewis Kuller
Journal:  Hypertension       Date:  2006-12-26       Impact factor: 10.190

7.  Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.

Authors:  Marilda Mazzali; John Kanellis; Lin Han; Lili Feng; Yi-Yang Xia; Qiang Chen; Duk-Hee Kang; Katherine L Gordon; Susumu Watanabe; Takahiko Nakagawa; Hui Y Lan; Richard J Johnson
Journal:  Am J Physiol Renal Physiol       Date:  2002-06

Review 8.  Peroxynitrite-induced oxidation and nitration products of guanine and 8-oxoguanine: structures and mechanisms of product formation.

Authors:  Jacquin C Niles; John S Wishnok; Steven R Tannenbaum
Journal:  Nitric Oxide       Date:  2005-12-13       Impact factor: 4.427

9.  Uric acid oxidation by peroxynitrite: multiple reactions, free radical formation, and amplification of lipid oxidation.

Authors:  C X Santos; E I Anjos; O Augusto
Journal:  Arch Biochem Biophys       Date:  1999-12-15       Impact factor: 4.013

10.  Nitric oxide inhibits prooxidant actions of uric acid during copper-mediated LDL oxidation.

Authors:  Silvia M Sanguinetti; Carlos Batthyány; Andrés Trostchansky; Horacio Botti; Graciela I López; Regina L W Wikinski; Homero Rubbo; Laura E Schreier
Journal:  Arch Biochem Biophys       Date:  2004-03-15       Impact factor: 4.013

View more
  36 in total

1.  Effect of uric acid lowering therapy on the prevention of acute kidney injury in cardiovascular surgery.

Authors:  A Ahsan Ejaz; Bhagwan Dass; Vijaykumar Lingegowda; Michiko Shimada; Thomas M Beaver; Noel I Ejaz; Amer S Abouhamze; Richard J Johnson
Journal:  Int Urol Nephrol       Date:  2012-05-31       Impact factor: 2.370

2.  Effect of febuxostat on oxidative stress in hemodialysis patients with endothelial dysfunction: a randomized, placebo-controlled, double-blinded study.

Authors:  Mona Alshahawey; Sara M Shaheen; Tamer Elsaid; Nagwa Ali Sabri
Journal:  Int Urol Nephrol       Date:  2019-08-01       Impact factor: 2.370

Review 3.  Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication.

Authors:  Jan-Bernd Funcke; Philipp E Scherer
Journal:  J Lipid Res       Date:  2019-06-17       Impact factor: 5.922

4.  Pro-inflammatory and oxidative effects of noncrystalline uric acid in human mesangial cells: contribution to hyperuricemic glomerular damage.

Authors:  M S Convento; E Pessoa; M A Dalboni; F T Borges; N Schor
Journal:  Urol Res       Date:  2010-06-04

5.  Uric acid inhibition of dipeptidyl peptidase IV in vitro is dependent on the intracellular formation of triuret.

Authors:  Rajesh Mohandas; Laura Sautina; Elaine Beem; Anna Schuler; Wai-Yan Chan; John Domsic; Robert McKenna; Richard J Johnson; Mark S Segal
Journal:  Exp Cell Res       Date:  2014-06-09       Impact factor: 3.905

Review 6.  Targeting urate to reduce oxidative stress in Parkinson disease.

Authors:  Grace F Crotty; Alberto Ascherio; Michael A Schwarzschild
Journal:  Exp Neurol       Date:  2017-06-13       Impact factor: 5.330

Review 7.  Uric acid and hypertension: cause or effect?

Authors:  Marilda Mazzali; Mehmet Kanbay; Mark S Segal; Mohamed Shafiu; Diana Jalal; Daniel I Feig; Richard J Johnson
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

8.  Assessment of cardiovascular risk profile based on measurement of tophus volume in patients with gout.

Authors:  Kyung-Ann Lee; Se-Ri Ryu; Seong-Jun Park; Hae-Rim Kim; Sang-Heon Lee
Journal:  Clin Rheumatol       Date:  2017-12-29       Impact factor: 2.980

9.  Triuret as a potential hypokalemic agent: Structure characterization of triuret and triuret-alkali metal adducts by mass spectrometric techniques.

Authors:  Sergiu P Palii; Cesar S Contreras; Jeffrey D Steill; Stela S Palii; Jos Oomens; John R Eyler
Journal:  Arch Biochem Biophys       Date:  2010-04-03       Impact factor: 4.013

10.  Simultaneous determination of uric acid metabolites allantoin, 6-aminouracil, and triuret in human urine using liquid chromatography-mass spectrometry.

Authors:  Kyung Mee Kim; George N Henderson; Reginald F Frye; Cheryl D Galloway; Nancy J Brown; Mark S Segal; Witcha Imaram; Alexander Angerhofer; Richard J Johnson
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-11-25       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.